Preparation of 211At-Labeled Humanized Anti-Tac Using 211At Produced in Disposable Internal and External Bismuth Targets
- 1 February 1998
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 25 (2) , 89-93
- https://doi.org/10.1016/s0969-8051(97)00165-0
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Evaluation of an internal cyclotron target for the production of 211At via the 209Bi (α,2n)211At reactionApplied Radiation and Isotopes, 1996
- Recombinant immunotoxins containing anti-Tac(Fv) and derivatives of Pseudomonas exotoxin produce complete regression in mice of an interleukin-2 receptor-expressing human carcinomaBlood, 1994
- N-Succinimidyl 4-methyl-3-(tri-n-butylstannyl)benzoate: Synthesis and potential utility for the radioiodination of monoclonal antibodiesNuclear Medicine and Biology, 1993
- The Multichain Interleukin-2 Receptor: A Target for ImmunotherapyAnnals of Internal Medicine, 1992
- A humanized antibody that binds to the interleukin 2 receptor.Proceedings of the National Academy of Sciences, 1989
- Labeling monoclonal antibodies and F(ab')2 fragments with the alpha-particle-emitting nuclide astatine-211: preservation of immunoreactivity and in vivo localizing capacity.Proceedings of the National Academy of Sciences, 1989
- Multichain Interleukin-2 Receptor: A Target for Immunotherapy in LymphomaJNCI Journal of the National Cancer Institute, 1989
- Bismuth-212-labeled anti-Tac monoclonal antibody: alpha-particle-emitting radionuclides as modalities for radioimmunotherapy.Proceedings of the National Academy of Sciences, 1986